Inhibrx Biosciences INBX - Options Chain | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Inhibrx Biosciences Inc (INBX)
Inhibrx Biosciences Inc (INBX) Options

Inhibrx Biosciences Inc (INBX)

15.12

0.15

(1.00%)

Closed 12 December 8:00AM

Delayed by 15 minutes

15.12

0.00

( 0.00% )

Pre Market: 1:04AM

Delayed by 15 minutes

INBX Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
12.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
15.00	1.10	1.10	1.10	1.10	0.00	0.00 %	0	43	-
17.50	0.35	0.35	0.35	0.35	0.00	0.00 %	0	6	-
17.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
20.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
20.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
22.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
22.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
25.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
25.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
30.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

Professional-Grade Tools, for Individual Investors.

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
12.50	0.45	0.45	0.45	0.45	0.00	0.00 %	0	10	-
15.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
17.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
17.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
20.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
20.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
22.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
22.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
25.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
25.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
30.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PALIPalisade Bio Inc	US$ 2.90 (107.14%)	26.55M
TRVITrevi Therapeutics Inc	US$ 4.47 (79.52%)	15.75M
LAESSEALSQ Corporation	US$ 1.6999 (47.82%)	42.6M
APVOAptevo Therapeutics Inc	US$ 14.41 (43.96%)	369.69k
SYTASiyata Mobile Inc	US$ 0.99 (32.35%)	20.13M
SPGCSacks Parente Golf Inc	US$ 0.295 (-78.93%)	4.7M
KROSKeros Therapeutics Inc	US$ 18.52 (-73.02%)	1.67M
TFFPTFF Pharmaceuticals Inc	US$ 0.084 (-48.37%)	1.03M
AVGRAvinger Inc	US$ 0.4398 (-46.37%)	190.83k
BCTXBriaCell Therapeutics Corporation	US$ 0.6899 (-37.28%)	1.45M
CDTConduit Pharmaceuticals Inc	US$ 0.1095 (24.01%)	54.17M
LAESSEALSQ Corporation	US$ 1.6999 (47.82%)	42.61M
PALIPalisade Bio Inc	US$ 2.90 (107.14%)	26.55M
SYTASiyata Mobile Inc	US$ 1.00 (33.69%)	20.13M
AMPGAmplitech Group Inc	US$ 2.26 (17.10%)	16.62M

Monksdream

Monksdream 2 months ago

Monksdream

Monksdream 3 months ago

Monksdream

Monksdream 3 months ago

Monksdream

Monksdream 8 months ago

TrendTrade2016

TrendTrade2016 2 years ago

heres the dolla...boom!!

TrendTrade2016

TrendTrade2016 2 years ago

INBX DOLLA RUMMER IN PROCESS

TrendTrade2016

TrendTrade2016 2 years ago

INBX...PRE MARKET VOL

Jaydixson1

Jaydixson1 2 years ago

Seems to be dropping

make it happen

make it happen 2 years ago

Numbers do not make sense. They need to raise so much to keep the Phases going. So much debt and money burn with worse quarters and barley any revs. Not bashing it's just what it is. 1,000's of percent's negative on profit. Revenue $0.18 Book Value -$0.12. Also imo this volume isn't sustainable 9 times normal as of now

Profitability
Profit Margin 0.00%
Operating Margin -1,448.76%

Management Effectiveness
Return on Assets -37.98%
Return on Equity -562.25%

Income Statement
Revenue 7.03M
Revenue Per Share 0.18
Quarterly Revenue Growth (yoy) -25.50%
Gross Profit -64.21M
EBITDA -100.6M
Net Income Avi to Common -110.75M
Diluted EPS -2.44

Balance Sheet
Total Debt 175.7M
Book Value Per Share -0.13

Cash Flow Statement
Operating Cash Flow -90.16M
Levered Free Cash Flow -46.31M

Inhibrx Biosciences

BNP Paribas Issuance

BNP Paribas Issuance

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions